Female sexual arousal disorder (FSAD) affects 43% of women in the United States today.

There are four variations of FSAD:

Hypoactive sexual desire disorder (low libido).

Sexual arousal disorder (poor sexual lubrication).

Orgasmic disorder (inability to reach orgasm).

Pain with intercourse.

FSAD not only affects a woman’s quality of life, body image, and relationship, but often also serves as a marker of a serious underlying medical disease such as diabetes, peripheral vascular disease, or depression.

At Protea the evaluation and treatment of FSAD relies upon comprehensive lab work and clinical experience.